SOMERVILLE, Mass., Feb. 26, 2026 /PRNewswire/ -- Generate Biomedicines, Inc. (Nasdaq: GENB) ("Generate"), a clinical-stage generative biology company pioneering the AI revolution in biotechnology and ...
Generate Capital – a leading sustainable infrastructure investment firm – announced a $1.2 billion revolving credit facility and term loan to support its goal of becoming the capital partner for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results